lunes, 29 de julio de 2024

FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products

https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded

No hay comentarios: